We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.5B
AUM Growth
+$748M
Cap. Flow
+$681M
Cap. Flow %
45.46%
Top 10 Hldgs %
71.8%
Holding
659
New
195
Increased
97
Reduced
113
Closed
226

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$521M
2
IBB icon
iShares Biotechnology ETF
IBB
+$149M
3
LLY icon
Eli Lilly
LLY
+$74.8M
4
GILD icon
Gilead Sciences
GILD
+$60.9M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$15.7M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$21.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$17M
3
AVGO icon
Broadcom
AVGO
+$16.6M
4
MRVL icon
Marvell Technology
MRVL
+$14.3M
5
TMUS icon
T-Mobile US
TMUS
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.98%
2 Technology 3.97%
3 Financials 3.94%
4 Consumer Discretionary 2.88%
5 Industrials 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
251
DELISTED
bluebird bio
BLUE
$468K 0.03%
3,382
– –
HLNE icon
252
Hamilton Lane
HLNE
$5.53B
$464K 0.03%
+7,263
New +$483K
KAMN
253
DELISTED
Kaman Corp
KAMN
$463K 0.03%
20,769
-1,875
-8% -$45.4K
GNTX icon
254
Gentex
GNTX
$5.02B
$462K 0.03%
16,960
-67,235
-80% -$1.79M
YELL
255
DELISTED
Yellow Corporation Common Stock
YELL
$462K 0.03%
184,153
-14,477
-7% -$51.5K
CBAY
256
DELISTED
Cymabay Therapeutics
CBAY
$462K 0.03%
73,649
+14,225
+24% +$54.1K
EQR icon
257
Equity Residential
EQR
$24.7B
$461K 0.03%
+7,815
New +$489K
MFIC icon
258
MidCap Financial Investment
MFIC
$797M
$459K 0.03%
40,231
-5,902
-13% -$68K
MNST icon
259
Monster Beverage
MNST
$89.6B
$455K 0.03%
+8,970
New +$434K
KSS icon
260
Kohl's
KSS
$2.16B
$453K 0.03%
17,939
-31,803
-64% -$902K
DINO icon
261
HF Sinclair
DINO
$15.2B
$452K 0.03%
8,715
-61
-0.7% -$3.51K
RDN icon
262
Radian Group
RDN
$4.87B
$450K 0.03%
+23,620
New +$460K
VIRT icon
263
Virtu Financial
VIRT
$4.92B
$450K 0.03%
+22,045
New +$479K
VEEV icon
264
Veeva Systems
VEEV
$38.1B
$435K 0.03%
2,695
-4,631
-63% -$791K
FSK icon
265
FS KKR Capital
FSK
$3.37B
$435K 0.03%
+24,846
New +$462K
BDN
266
Brandywine Realty Trust
BDN
$530M
$432K 0.03%
70,168
-58,842
-46% -$378K
WH icon
267
Wyndham Hotels & Resorts
WH
$5.29B
$430K 0.03%
6,035
-11,500
-66% -$813K
USNA icon
268
Usana Health Sciences
USNA
$265M
$430K 0.03%
8,087
-8,034
-50% -$435K
CGBD icon
269
Carlyle Secured Lending
CGBD
$766M
$429K 0.03%
+29,949
New +$400K
LBTYA icon
270
Liberty Global Class A
LBTYA
$3.46B
$423K 0.03%
22,339
+4,824
+28% +$87.8K
DYN icon
271
Dyne Therapeutics
DYN
$4.95B
$421K 0.03%
+36,360
New +$421K
OCSL icon
272
Oaktree Specialty Lending
OCSL
$1.12B
$416K 0.03%
+20,173
New +$406K
GRTS
273
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$414K 0.03%
120,134
+24,944
+26% +$71.2K
MMM icon
274
3M
MMM
$93.9B
$413K 0.03%
4,123
-13,733
-77% -$1.4M
TSLX icon
275
Sixth Street Specialty
TSLX
$1.79B
$410K 0.03%
+23,060
New +$413K
9 10
11
12 13

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.

  • Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
  • Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
  • Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
  • Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
  • Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
  • Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.